Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain

J Clin Oncol. 2022 Mar 1;40(7):693-697. doi: 10.1200/JCO.21.02550. Epub 2022 Jan 24.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Receptor, ErbB-2

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2